reuters.com/article/2015/04/10/astrazeneca-onglyza-fda-idUSL2N0X70PU20150410 …
Informe original de la FDA
http://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/UCM442060.pdf …
No hay comentarios:
Publicar un comentario